StockData
Opus Genetics, Inc. logo

Opus Genetics, Inc. (IRD) stock

IRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$3.92−0.13 (-3.21%)

Close on Nov 18, 2026Market cap $326.13MP/E –Yield –

Opus Genetics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Opus Genetics's pe ratio was 2.1× on Jan 31, 2024.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Jan 31, 20242.1×−0.3
2023Dec 29, 20232.4×–

More Opus Genetics figures

See a number that looks wrong?